
    
      The aim of this study was to examine the effects of the use of fluoroquinolones a class of
      antibiotics introduced relatively recently, in a particular population of patients with acute
      exacerbation of COPD, previously treated unsuccessfully with other antibiotics, and
      hospitalized in Internal Medicine. These patients reflect the reality of patients admitted to
      Internal Medicine, they are characterized by a high frequency of advanced age, polypathology,
      with multiple treatments.
    
  